<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - AstraZeneca</title>
    <link>http://www.newstin.com/us/ASTRAZENECA</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Two drugs don't boost lung cancer survival: Roche (Reuters)</title>
      <link>http://www.newstin.com/tag/us/79527403</link>
      <description>Reuters - Roche Holding AG and Genentech Inc said on Monday a study into the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.</description>
      <pubDate>Mon, 06 Oct 2008 09:47:18 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79527403</guid>
      <dc:date>2008-10-06T09:47:18Z</dc:date>
    </item>
    <item>
      <title>International Implementation of Breast Health Guidelines for Developing Countries Published by...</title>
      <link>http://www.newstin.com/tag/us/79548113</link>
      <description>A special supplement of the Oct. 15 journal Cancer for the first time details guidelines for low- and middle-income countries to implement breast cancer programs to detect and treat the most common disease among women worldwide.</description>
      <pubDate>Mon, 06 Oct 2008 11:28:30 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79548113</guid>
      <dc:date>2008-10-06T11:28:30Z</dc:date>
    </item>
    <item>
      <title>Minner in Europe for trade mission</title>
      <link>http://www.newstin.com/tag/us/79520232</link>
      <description>Surprise trip follows state revenue declines By GINGER GIBSON • The News Journal • October 6, 2008 Less than three months from the end of her tenure, Gov. Ruth Ann Minner left the country unannounced Saturday on an...</description>
      <pubDate>Mon, 06 Oct 2008 05:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79520232</guid>
      <dc:date>2008-10-06T05:00:00Z</dc:date>
    </item>
    <item>
      <title>New Drug-Coated Stent Grabs Market Share, Exceeds Expectations (Investor's Business Daily)</title>
      <link>http://www.newstin.com/tag/us/79559728</link>
      <description>Abbott (NYSE:ABT - News ) has sold its Xience V drug-coated stent in the U.S. since it got the Food and Drug Administration's nod in July. Xience, combined with a private-label version called Promus, grabbed about half the...</description>
      <pubDate>Mon, 06 Oct 2008 12:28:27 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79559728</guid>
      <dc:date>2008-10-06T12:28:27Z</dc:date>
    </item>
    <item>
      <title>Supplier relationship management in the Pharmaceutical Industry</title>
      <link>http://www.newstin.com/tag/us/79489039</link>
      <description>Frankfurt, (ANTARA News/PRNewswire-AsiaNet) -- With continued pressure on pharma companies to reduce their cost base, procurement departments are seeking innovative ways of managing their complex supplier base in order to...</description>
      <pubDate>Mon, 06 Oct 2008 04:56:02 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79489039</guid>
      <dc:date>2008-10-06T04:56:02Z</dc:date>
    </item>
    <item>
      <title>API sourcing strategies 24 - 25th Nov. Bristol, Berlin, Germany</title>
      <link>http://www.newstin.com/tag/us/79489028</link>
      <description>Berlin, (ANTARA News/PRNewswire-AsiaNet -- Rising API prices in traditional low-cost countries are now fundamentally impacting API sourcing strategies. Additionally, increases in IP theft, contamination of goods and a changing...</description>
      <pubDate>Mon, 06 Oct 2008 04:55:54 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79489028</guid>
      <dc:date>2008-10-06T04:55:54Z</dc:date>
    </item>
    <item>
      <title>/R E P R I S E -- Montréal International welcomes the business community to a major conference on...</title>
      <link>http://www.newstin.com/tag/us/79529679</link>
      <description>MONTREAL, Oct. 2 /CNW Telbec/ - Today, at Centre Mont-Royal, is the opening of Innovation Montréal 2008, an international conference on innovation and business development. Over 300 participants have already confirmed their...</description>
      <pubDate>Mon, 06 Oct 2008 10:24:56 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79529679</guid>
      <dc:date>2008-10-06T10:24:56Z</dc:date>
    </item>
    <item>
      <title>Award forIn the Pink research ... again</title>
      <link>http://www.newstin.com/tag/us/79498988</link>
      <description>Oct 6 2008 by Madeleine Brindley, Western Mail RESEARCH funded by a former breast cancer patient and her friends in Wales has won an international award for the second year running. The In the Pink Foundation research at...</description>
      <pubDate>Sun, 05 Oct 2008 23:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79498988</guid>
      <dc:date>2008-10-05T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Leading U.S. psychiatrist failed to report drug income</title>
      <link>http://www.newstin.com/tag/us/79154616</link>
      <description>One of the nation's most influential psychiatrists earned more than $2.8 million in consulting arrangements with drug makers between 2000 and 2007, failed to report at least $1.2 million of this income to his university, and...</description>
      <pubDate>Fri, 03 Oct 2008 15:40:39 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79154616</guid>
      <dc:date>2008-10-03T15:40:39Z</dc:date>
    </item>
    <item>
      <title>Micromet Closes $40 Million Private Equity Placement (PR Newswire)</title>
      <link>http://www.newstin.com/tag/us/79095264</link>
      <description>Friday October 3, 7:00 am ET Funding Proceeds to Support R&amp;D Efforts and Clinical Trials Advancing the BiTE Therapeutic Antibody Platform BETHESDA, Md., Oct. 3 /PRNewswire-FirstCall/ -- Micromet's President and CEO, Christian...</description>
      <pubDate>Fri, 03 Oct 2008 11:33:39 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/79095264</guid>
      <dc:date>2008-10-03T11:33:39Z</dc:date>
    </item>
  </channel>
</rss>

